# FDA recall D-0807-2023

> **Akorn, Inc.** · Class II · drug recall initiated 2023-04-26.

## Product

Guaiatussin AC Sugar-Free, Each teaspoonful (5 mL) contains: Guaifenesin (100 mg), Codeine Phosphate (10 mg), Alcohol (3.5% v/v), a) packaged in a) 118 mL bottles, b) 473 mL bottles and c) 100 unit dose cups, Rx Only, Distributed by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs

## Reason for recall

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

## Distribution

Nationwide in the USA and Puerto Rico

## Key facts

- **Recall number:** D-0807-2023
- **Recalling firm:** Akorn, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2023-04-26
- **Report date:** 2023-06-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Gurnee, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0807-2023

## Citation

> AI Analytics. FDA recall D-0807-2023. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0807-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*